Abstract
Introduction
[8] and mechanical [9] stimuli in vitro and in the adverse ventricular remodelling that occurs following myocardial
The sarcolemmal Na / H exchanger (NHE) is encoded infarction in vivo [10] [11] [12] . Perhaps the strongest exby the NHE-1 gene [1] and contributes to the integrated perimental evidence for a pathophysiological role for the control of intracellular pH (pH ) in cardiac myocytes [2] .
sarcolemmal NHE, however, is that which implicates the i Basal activity of the sarcolemmal NHE is low under exchanger in the development of myocardial injury and physiological conditions [2] but increased exchanger acdysfunction during ischaemia and reperfusion (see reviews 1 tivity and resultant increases in intracellular Na and / or by Avkiran [13] and Karmazyn et al. [14] ). Importantly, pH may mediate the inotropic responses of myocardium to recent studies suggest that NHE inhibition by the NHE-1-i neurohormonal stimuli [3-6] and myocardial stretch [7] . selective inhibitor cariporide may provide cardioprotective With respect to cardiac pathophysiology, sarcolemmal benefit in certain clinical settings also, such as in high-risk NHE activity may play a permissive role in the hypatients who are subjected to elective myocardial ispertrophic response of cardiac myocytes to neurohormonal chaemia and reperfusion during coronary artery bypass graft surgery [15] . There is strong evidence that oxidative stress also contributes to the development of myocardial injury and cSNARF-1, using a microepifluorescence technique [26- MAPK activities were determined through the detection of on sarcolemmal NHE activity in adult myocardium and the dual phosphorylation of ERK1 / 2 and p38 MAPK by signalling mechanism(s) underlying any such effects are immunoblot analysis using phosphospecific antibodies unknown. Notably, qualitative and quantitative changes are (New England BioLabs, MA), as described previously rsk known to occur during post-natal development in the [27, 28] . Activities of p90 and Src tyrosine kinase were 381 416 myocardial expression of NHE-regulatory signalling moledetermined by the detection of Ser or Tyr phoscules, such as ERK [21] and protein kinase C (PKC) phorylation, respectively, using phosphospecific antibodies [22] [23] [24] . Furthermore, the basal expression and activity of (New England BioLabs) [27, 28] . To confirm equal protein NHE differs significantly between neonatal and adult rat loading, non-phosphospecific antibodies for ERK2, p38, of .80% rod-shaped myocytes, as described previously activity, myocytes were subjected to intracellular acidosis [26] .
by transient exposure to 20 mM NH Cl (first acid pulse), 4 which was repeated 17-27 min later (second acid pulse Sarcolemmal NHE activity was determined in quiescent (Sigma-Aldrich, Poole, UK) from 10 min before the single myocytes loaded with the pH-sensitive fluoroprobe second acid pulse (see Fig. 1A ). Time-dependent effects were assessed by exposing cells to vehicle or 100 mM extended to 20 and 30 min. When studying the effects of H O from 3, 6 or 10 min before the second acid pulse PD98059 (10 mM) or SB203580 (1 mM) on H O -induced 2 2 2 2 (see Fig. 1B ). When studying the effects of the MEK kinase activation, this was present from 10 min before the inhibitor PD98059 (10 mM), the p38 MAPK inhibitor start of exposure to 100 mM H O (10 min), as above.
2 2 SB203580 (1 mM) or the PKC inhibitor GF109203X (1 When studying the effects of PKC inhibitors (GF109203X mM) (all from Calbiochem-Novabiochem, Nottingham, and chelerythrine), the non-selective tyrosine kinase inhib-UK), the kinase inhibitor was present from 10 min before itor genistein, the Src family kinase inhibitor PP2 and the the start of exposure to 100 mM H O (see on the basis of our earlier work on receptor-mediated NHE induced kinase activation, various concentrations of each regulation in the same preparation [27, 28] and the coninhibitor were present from 30 min before the start of centration of SB203580 was selected since it fully inhibits exposure to 100 mM H O (10 min).
experiments, cells from one heart were used on each day and these were allocated in a randomised manner to the experimental groups of the protocol under study; eight to 10 separate hearts were required to complete each protocol (see figure legends), within which each experimental group comprised seven to 10 myocytes. The biochemical experiments were repeated four times, each time using myocytes from a separate heart. For inter-group comparison of DJ H or protein kinase phosphorylation, data were subjected to ANOVA; further analysis was by Dunnett's test, to compare each treatment group with the control group. P,0.05 was considered significant. sarcolemmal NHE activity in a dose-dependent manner, such that .10 mM H O is required to achieve a signifi-2 2 cant effect.
Results

Effects of H O on sarcolemmal NHE activity
Time-response studies
These experiments were performed to delineate the temporal profile of H O -induced stimulation of NHE 2 2 activity. Consistent with the above results, a 10-min exposure to 100 mM H O again produced a significant 2 2 increase in DJ (Fig. 2B) . However, when exposure time second acid pulse. *P,0.05 versus control (seven to 10 cells per group, obtained from 10 hearts). of cells to 1-1000 mM H O for 10 min produced dosebased on the change in the phosphorylation status of 2 2 dependent activation of both ERK1 / 2 and p38 MAPK, ERK2. The temporal profiles indicated that peak ERK and with significant increases in activity achieved with 100 mM p38 MAPK activation occurred after 6 min of exposure to H O (Fig. 3A) . These data also showed that in adult rat 100 mM H O , and that such activation was sustained for approximately 10 min (Fig. 3B) . The concordance between ty. In the absence of any pre-treatment, a 10-min exposure the dose-and time-dependence characteristics of H Oto 100 mM H O again produced a significant increase in 2 2 2 2 induced activation of ERK and p38 MAPK and H O -DJ (Fig. 4A ). This effect was abolished by pre-treatment 2 2 H induced stimulation of sarcolemmal NHE activity suggests of cells with the MEK inhibitor PD98059 but was unafthat either kinase may play a role in the latter response.
Effect of H O on cellular ERK and p38 MAPK
fected by pre-treatment with the p38 MAPK inhibitor SB203580 (Fig. 4A) NHE stimulation occurred through the predicted mecha-NHE activity. nism of MEK inhibition, we next determined its effect on ERK activity. As shown in Fig. 5, a 10- Here, we tested whether this holds true also for H O -2 2
induced stimulation of sarcolemmal NHE activity. As shown in Fig. 6 , pre-treatment with the PKC inhibitor GF109203X (used at a concentration of 1 mM, which we have shown previously to inhibit phorbol ester-induced effects in an identical preparation [28] ) completely abolished the H O -induced increase in DJ . This suggests 2 2 H rsk that, in addition to ERK / p90 activation, PKC activation is also necessary for the stimulation of sarcolemmal NHE activity by H O . induced ERK activation has been suggested to occur through a PKC-mediated mechanism [20, 34] . However, when we examined the effects of GF109203X (Fig. 7A ) through PKC-independent mechanisms. (Fig. 8A) . Daidzein, a structural analog of genistein without tyrosine kinase inhibitory activity, had no effect on In the light of the above, we examined whether H Othe H O -induced response. Thus, relative to control, (Fig. 8B) , indicating a key role for Src family tyrosine kinases in this response. Indeed, Src tyrosine kinase was found to be activated rapidly upon exposure to H O (Fig. 9) , which supports a proximal role for Src- ERK activity. In other cell types, c-Src (a member of the Src family) can phosphorylate the EGF receptor and thereby facilitate its full activation [36] , and activation of this receptor tyrosine kinase has been implicated in ERK activation by H O [37] . We therefore also investigated the 2 2 effects of the EGF receptor kinase inhibitor AG1478 in our adult myocyte system. The data revealed that AG1478 inhibited H O -induced ERK activation in a dose-depen-2 2 dent manner (Fig. 8C) , suggesting that the signalling mechanisms underlying this response are likely to involve stimulates sarcolemmal NHE activity in freshly isolated adult rat ventricular myocytes. Our data extend earlier processes that are likely to mediate H O -induced stimula- pears to occur through the activation of tyrosine kinases of nant PKC isozymes in adult rat myocardium [24] ), in both receptor and non-receptor families.
Proximal regulators of ERK activity: role of tyrosine kinases
transfected COS-7 cells, through tyrosine phosphorylation Fig. 10 is based on the data obtained in the present study by unidentified kinases [38] . ERK is also activated by with rationally selected concentrations of specific kinase H O , as shown by previous work in neonatal myocytes 2 2
inhibitors (shown in italics) and the information that is [20, 34, 35] and the present study in adult myocytes. available in the literature, and illustrates the signalling Although it has been suggested that this activation may occur through a PKC-mediated pathway in cultured neonatal myocytes [20, 34] , contradictory data have also been reported [35] . Our present data with GF109203X and chelerythrine oppose a PKC-mediated mechanism for H O -induced ERK activation in freshly isolated adult 2 2 myocytes. Instead, our data suggest that ERK activation in these cells occurs through tyrosine kinase-mediated mechanisms that involve both Src family enzymes (which are inhibited selectively by PP2) and the EGF receptor (which is inhibited selectively by AG1478 activates Src, as well as ERK and p90 [39] . Furthermore, in neonatal myocytes, overexpression of C-terminal Src kinase (a negative regulator of Src family tyrosine kinases) by transfection has been shown to inhibit H O -2 2 induced ERK activation [35] . On the basis of the above, it is likely that H O activates PKC through tyrosine phos-2 2 phorylation (by an as yet unidentified kinase) and ERK through Src-dependent EGF receptor activation and subsequent stimulation of the classical Ras-Raf-MEK pathway.
A potential limitation of the present study is the reliance on pharmacological kinase inhibitors to dissect the intracellular signalling pathways that mediate H O -induced
